Titre:
  • CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF.
Auteur:Baba, Nobuyasu; Van, Vu Quang; Wakahara, Keiko; Rubio, Manuel; Fortin, Geneviève; Panzini, Benoît; Soucy, Geneviève; Wassef, Ramses; Richard, Carole; Tamaz, Raja; Lahaie, Raymond; Bernard, Edmond-Jean; Caussignac, Yves; Leduc, Raymond; Lougnarath, Rasmy; Bergeron, Carole; Racicot, Marc-André; Bergeron, Fanny; Panzini, Marie-Andrée; Demetter, Pieter; Franchimont, Denis; Schäkel, Knut; Weckbecker, Gisbert; Kolbinger, Frank; Heusser, Christoph; Huber, Thomas; Welzenbach, Karl; Sarfati, Marika
Informations sur la publication:The Journal of experimental medicine, 210, 6, page (1251-1263)
Statut de publication:Publié, 2013-06
Sujet CREF:Anatomopathologie
MeSH keywords:Antigens, CD47 -- metabolism
Antigens, Differentiation -- metabolism
Cadherins -- metabolism
Crohn Disease -- immunology
Dendritic Cells -- metabolism
HLA-DR Antigens -- metabolism
Humans
Inflammation -- metabolism
Interleukin-1beta -- metabolism
Intestinal Mucosa -- metabolism
Lymph Nodes -- metabolism
Monocytes -- metabolism
Receptors, Chemokine -- metabolism
Receptors, Immunologic -- metabolism
Recombinant Fusion Proteins -- metabolism
Th1 Cells -- metabolism
Th17 Cells -- metabolism
Tumor Necrosis Factor-alpha -- metabolism
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0022-1007
info:doi/10.1084/jem.20122037
info:pii/jem.20122037
info:scp/84880649447
info:pmid/23669395
PMC3674701